Thomas Gabrielczyk

Thomas Gabrielczyk currently serves as the Editor-in-Chief at BIOCOM AG, where he plays a pivotal role in shaping the company's strategic communication and thought leadership in the biotechnology sector. His extensive background as a seasoned science writer across a diverse array of specialized and public journals—such as BIOspektrum, BioEngineering, European Biotechnology Magazine, and GEO—equips him with a comprehensive understanding of the latest advancements in life sciences, biotechnologies, and related fields. At BIOCOM AG, Thomas leverages this expertise to oversee the evaluation, description, and dissemination of cutting-edge biotechnological innovations, ensuring that complex scientific concepts are communicated clearly and effectively to both industry stakeholders and the broader public.

In his current role, Thomas is deeply involved in curating content that highlights emerging trends in biotech research, bioinformatics, and medical technologies, often integrating insights from EU research funding policies, biotech startups, and research institutions. His proficiency in scientific writing, combined with skills in SEO and public relations, enables him to craft compelling narratives that enhance BIOCOM’s visibility and influence within the biotech ecosystem. Additionally, Thomas’s experience in designing PR campaigns and managing media relations ensures that BIOCOM’s initiatives resonate across multiple channels, fostering engagement with policymakers, investors, and scientific communities alike. His ability to evaluate novel technologies and translate complex scientific data into accessible formats makes him an invaluable asset in advancing BIOCOM AG’s mission to promote innovation and collaboration within the biotechnology industry.